[go: up one dir, main page]

HK1245669B - 胰高血糖素和glp-1協同激動劑化合物 - Google Patents

胰高血糖素和glp-1協同激動劑化合物 Download PDF

Info

Publication number
HK1245669B
HK1245669B HK18105443.2A HK18105443A HK1245669B HK 1245669 B HK1245669 B HK 1245669B HK 18105443 A HK18105443 A HK 18105443A HK 1245669 B HK1245669 B HK 1245669B
Authority
HK
Hong Kong
Prior art keywords
glu
gly
lys
acid
ser
Prior art date
Application number
HK18105443.2A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1245669A1 (zh
Inventor
Yanyun Chen
Adam Robert MEZO
Hongchang Qu
Francisco Alcides VALENZUELA
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Priority claimed from PCT/US2016/037818 external-priority patent/WO2016209707A1/en
Publication of HK1245669A1 publication Critical patent/HK1245669A1/zh
Publication of HK1245669B publication Critical patent/HK1245669B/zh

Links

HK18105443.2A 2015-06-22 2016-06-16 胰高血糖素和glp-1協同激動劑化合物 HK1245669B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562182847P 2015-06-22 2015-06-22
US62/182,847 2015-06-22
PCT/US2016/037818 WO2016209707A1 (en) 2015-06-22 2016-06-16 Glucagon and glp-1 co-agonist compounds

Publications (2)

Publication Number Publication Date
HK1245669A1 HK1245669A1 (zh) 2018-08-31
HK1245669B true HK1245669B (zh) 2021-02-26

Family

ID=

Similar Documents

Publication Publication Date Title
EP3310371B1 (en) Glucagon and glp-1 co-agonist compounds
EP3727426B1 (en) Incretin analogs and uses thereof
EP3368061B1 (en) Glucagon receptor agonists
AU2010341651B2 (en) Oxyntomodulin peptide analogue
US8415296B2 (en) Oxyntomodulin peptide analogue
HK1245669B (zh) 胰高血糖素和glp-1協同激動劑化合物
BR112017024684B1 (pt) Compostos coagonistas de glucagon e glp-1, composição farmacêutica, uso, processo de produção e composto intermediário dos mesmos
EA048990B1 (ru) Коагонист рецептора glp-1 и рецептора глюкагона для лечения диабета 2 типа, ожирения, неалкогольной жировой болезни печени и/или неалкогольного стеатогепатита